₹ 23.10
0.43 (1.90%)
NSE
B
Balaxi Pharmaceuticals
₹ 23.10
NSE
Balaxi Pharmaceuticals Fundamentals
Company Valuation
Market Cap (₹ Cr.)
128
PE Ratio
51.50
PB Ratio
0.50
Dividend Yield
2.21%
ROE
0.57%
ROCE
3.35%
Book Value (₹)
45.12
Face Value (₹)
2.00
Analyse BALAXI with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| Domestic Institutional Investors (DII) | 0.02% | 0.02% | 2.56% | 2.56% | 2.56% |
| Foreign Institutional Investors (FII) | 0.00% | 1.74% | 0.00% | 0.00% | 0.00% |
| Public Investors | 20.03% | 22.39% | 24.41% | 24.43% | 24.29% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BALAXI Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
0
NSE Scrip Name
BALAXI
ISIN
INE618N01022

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






